Alnylam Pharmaceuticals (ALNY) News Today $452.00 -4.35 (-0.95%) Closing price 04:00 PM EasternExtended Trading$455.00 +3.00 (+0.66%) As of 06:50 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock ALNY Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 Time Period Morgan Stanley Raises Alnylam Pharmaceuticals (NASDAQ:ALNY) Price Target to $475.00October 6 at 10:09 AM | marketbeat.comAlnylam Pharmaceuticals (NASDAQ:ALNY) Given New $495.00 Price Target at Stifel NicolausOctober 6 at 8:51 AM | marketbeat.comAlnylam Pharmaceuticals (NASDAQ:ALNY) Upgraded to "Strong-Buy" at Wall Street ZenOctober 5 at 3:19 AM | americanbankingnews.comAMF Tjanstepension AB Makes New $10.61 Million Investment in Alnylam Pharmaceuticals, Inc. $ALNYOctober 4 at 6:46 AM | marketbeat.comInsider Selling: Alnylam Pharmaceuticals (NASDAQ:ALNY) EVP Sells 1,405 Shares of StockOctober 4 at 5:57 AM | insidertrades.comRobeco Institutional Asset Management B.V. Trims Holdings in Alnylam Pharmaceuticals, Inc. $ALNYOctober 4 at 3:54 AM | marketbeat.comAlnylam Pharmaceuticals (NASDAQ:ALNY) Upgraded to Strong-Buy at Wall Street ZenOctober 4 at 3:19 AM | marketbeat.comAlnylam Pharmaceuticals (NASDAQ:ALNY) EVP Tolga Tanguler Sells 1,405 SharesOctober 3 at 6:38 PM | marketbeat.comKevin Joseph Fitzgerald Sells 2,441 Shares of Alnylam Pharmaceuticals (NASDAQ:ALNY) StockOctober 3 at 6:38 PM | marketbeat.comInsider Selling: Alnylam Pharmaceuticals (NASDAQ:ALNY) EVP Sells 2,937 Shares of StockOctober 3 at 6:38 PM | marketbeat.comAlnylam Pharmaceuticals (NASDAQ:ALNY) EVP Sells $1,364,372.56 in StockOctober 3 at 6:38 PM | marketbeat.comAlnylam Pharmaceuticals (NASDAQ:ALNY) EVP Sells $1,727,283.05 in StockOctober 3 at 6:38 PM | marketbeat.comAlnylam Pharmaceuticals (NASDAQ:ALNY) CEO Sells $4,034,094.20 in StockOctober 3 at 6:38 PM | marketbeat.comAlnylam Pharma Secures $500M Credit AgreementOctober 3 at 4:50 PM | tipranks.comAlnylam Pharmaceuticals, Inc. $ALNY Shares Sold by J. Safra Sarasin Holding AGOctober 3 at 5:05 AM | marketbeat.com8,322 Shares in Alnylam Pharmaceuticals, Inc. $ALNY Purchased by Lbp Am SaOctober 3 at 4:03 AM | marketbeat.comAlnylam pulls heart drug TV ad amid FDA crackdownOctober 2, 2025 | investing.comCambridge-based Alnylam Pharmaceuticals pulls TV ad after Trump crackdown on drug industry spotsOctober 2, 2025 | bostonglobe.comBWealth Enhancement Slashes Alnylam Pharmaceuticals, Inc. (ALNY) Stake by 64.5%October 2, 2025 | insidermonkey.comAlnylam (ALNY) Reports 238% Growth in Amvuttra Since February Launch, RBC Raises Price TargetOctober 2, 2025 | msn.comAlnylam Pharmaceuticals, Inc. (ALNY) Reports $492M Amvuttra Sales, Raises 2025 Revenue GuidanceOctober 1, 2025 | finance.yahoo.comJefferies Sticks to Their Hold Rating for Aurinia Pharmaceuticals (AUPH)October 1, 2025 | theglobeandmail.com7 Most Promising Biotech Stocks to Buy According to Hedge FundsOctober 1, 2025 | insidermonkey.comAlnylam’s AMVUTTRA Reduces GI Events in ATTR-CM Patients, According to New HELIOS-B DataOctober 1, 2025 | finance.yahoo.comAlnylam Pharmaceuticals, Inc. $ALNY Shares Bought by V Square Quantitative Management LLCOctober 1, 2025 | marketbeat.comDividend Reset = Opportunity to Grab This 9.2% Yield at a Discount...September 30, 2025 | marketbeat.comAlnylam Pharmaceuticals, Inc. (ALNY) Reports $492M Amvuttra Sales, Raises 2025 Revenue GuidanceSeptember 30, 2025 | insidermonkey.comWealth Enhancement Advisory Services LLC Cuts Stock Position in Alnylam Pharmaceuticals, Inc. $ALNYSeptember 30, 2025 | marketbeat.com2,085 Shares in Alnylam Pharmaceuticals, Inc. $ALNY Acquired by Park Avenue Securities LLCSeptember 29, 2025 | marketbeat.comAlnylam announces results from HELIOS-B Phase 3 study of AMVUTTRASeptember 29, 2025 | msn.comNew Data from HELIOS-B Phase 3 Study Demonstrate Lower Rates of Gastrointestinal Events in ATTR-CM Patients Treated with VutrisiranSeptember 28, 2025 | businesswire.comAlnylam Pharmaceuticals, Inc. $ALNY Shares Sold by Public Employees Retirement System of OhioSeptember 27, 2025 | marketbeat.comSowell Financial Services LLC Takes $201,000 Position in Alnylam Pharmaceuticals, Inc. $ALNYSeptember 27, 2025 | marketbeat.comTrump’s drug tariffs are days away. Massachusetts’ pharma companies aren’t worriedSeptember 26, 2025 | bostonglobe.comB$1000 Invested In Alnylam Pharmaceuticals 5 Years Ago Would Be Worth This Much TodaySeptember 26, 2025 | benzinga.com8,994 Shares in Alnylam Pharmaceuticals, Inc. $ALNY Purchased by ST Germain D J Co. Inc.September 26, 2025 | marketbeat.comSeptember 2025's Top Stocks Estimated To Be Trading Below Fair ValueSeptember 25, 2025 | finance.yahoo.comIs Alnylam Pharmaceuticals (ALNY) an Undervalued Stock?September 25, 2025 | insidermonkey.comTB Alternative Assets Ltd. Lowers Position in Alnylam Pharmaceuticals, Inc. $ALNYSeptember 25, 2025 | marketbeat.comBannerman Wealth Management Group LLC Sells 565 Shares of Alnylam Pharmaceuticals, Inc. $ALNYSeptember 24, 2025 | marketbeat.comAssenagon Asset Management S.A. Purchases 11,281 Shares of Alnylam Pharmaceuticals, Inc. $ALNYSeptember 24, 2025 | marketbeat.comExchange Traded Concepts LLC Sells 909 Shares of Alnylam Pharmaceuticals, Inc. $ALNYSeptember 24, 2025 | marketbeat.comAlnylam Pharmaceuticals, Inc. (ALNY) Presents at Bernstein Insights: Healthcare Leaders and Disruptors - 2nd Annual Healthcare Forum TranscriptSeptember 23, 2025 | seekingalpha.comWith DTC ads under fire, pharma companies need to pivotSeptember 22, 2025 | finance.yahoo.comU.S. Capital Wealth Advisors LLC Sells 3,984 Shares of Alnylam Pharmaceuticals, Inc. $ALNYSeptember 22, 2025 | marketbeat.comIFM Investors Pty Ltd Boosts Stake in Alnylam Pharmaceuticals, Inc. $ALNYSeptember 21, 2025 | marketbeat.comSwedbank AB Has $20.97 Million Position in Alnylam Pharmaceuticals, Inc. $ALNYSeptember 21, 2025 | marketbeat.comDoes Alnylam's Entry Into the Genomics Alliance Hint at a New Era for Illumina (ILMN) R&D?September 20, 2025 | finance.yahoo.comRoyal Bank Of Canada Raises Alnylam Pharmaceuticals (NASDAQ:ALNY) Price Target to $500.00September 20, 2025 | marketbeat.comSumitomo Mitsui DS Asset Management Company Ltd Raises Position in Alnylam Pharmaceuticals, Inc. $ALNYSeptember 20, 2025 | marketbeat.com Get Alnylam Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for ALNY and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ALNY Media Mentions By Week ALNY Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ALNY News Sentiment▼0.630.54▲Average Medical News Sentiment ALNY News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ALNY Articles This Week▼3621▲ALNY Articles Average Week Get the Latest News and Ratings for ALNY and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Alnylam Pharmaceuticals and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Amgen News Gilead Sciences News Vertex Pharmaceuticals News Regeneron Pharmaceuticals News Biogen News United Therapeutics News Incyte News Neurocrine Biosciences News Exelixis News BioMarin Pharmaceutical News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ALNY) was last updated on 10/6/2025 by MarketBeat.com Staff From Our PartnersGold surges past $3,600 … but this has beat gold by 1,000xGold has surged past $3,600 an ounce — up 45% in the past year — but one veteran metals analyst says the real ...Weiss Ratings | SponsoredElon’s Out 🚫. Trump’s DOGE Payouts Keep Flowing (Up to $32K a Year)DOGE payouts are already moving. Every 90 days, billions flow out — whether you’ve claimed your share or not. ...Angel Publishing | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredWarren Buffett’s #1 AI Stock is Not Even on the NasdaqNew Amazon Crisis Could Tank U.S. Stock Market A new panic is halting AI projects at Amazon and could split...Altimetry | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…A Millionaire With SEVEN Clicks? $1,000 in just seven stocks in 2004 could have turned into a million-dolla...The Oxford Club | SponsoredMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alnylam Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Alnylam Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
